31 results on '"Clarke, Stephen John"'
Search Results
2. Safety and efficacy of the anti-CD73 monoclonal antibody (mAb) oleclumab ± durvalumab in patients (pts) with advanced colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), or EGFR-mutant non-small cell lung cancer (EGFRm NSCLC).
3. Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).
4. An oro-buccal nanoparticle delivered cannabis medicine for pain management in cancer: A clinical trial in progress.
5. The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]
6. Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer
7. Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study
8. Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase 3 study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial.
9. Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).
10. Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV).
11. Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection.
12. The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab.
13. CheckMate 577: A randomized, double-blind, phase 3 study of adjuvant nivolumab (nivo) or placebo in pts with resected esophageal (E) or gastroesophageal junction (GEJ) cancer.
14. Afatinib in patients with metastatic HER2-mutant lung cancers: An international multicenter study.
15. Colorectal cancer sidedeness and its association with survival and tumor biology in operable patients.
16. Liquid biopsy in the clinic: A prospective study of plasma circulating tumor DNA (ctDNA) next generation sequencing (NGS) in patients with advanced non-small cell lung cancers to match targeted therapy.
17. CheckMate 577: A randomized, double-blind, phase 3 study of nivolumab (Nivo) or placebo in patients (Pts) with resected lower esophageal (E) or gastroesophageal junction (GEJ) cancer.
18. Change in inflammatory status as a prognostic marker of overall survival in colorectal patients undergoing resection.
19. Adjuvant therapy in pancreatic adenocarcinoma: A systemic review and meta-analysis.
20. The lymphocyte-to-monocyte ratio as a predictor of overall survival in comparison to established systemic markers of inflammation in resectable colorectal cancer.
21. Preliminary direct evidence of a dose-response relationship for [Y-90]-microsphere selective internal radionuclide therapy (SIRT) in hepatic malignancy.
22. The impact of physical activity on fatigue and quality of life in lung cancer patients: A randomised controlled trial (RCT).
23. Neutrophil/lymphocyte ratio (NLR) and FDG PET as predictive measures of response and prognosis in patients treated with Y-90 microsphere selective internal radionuclide therapy (SIRT).
24. Prognostic significance of circulating secreted protein acidic and rich in cysteine (SPARC) in malignant pleural mesothelioma (MPM).
25. Old and new prognostic factors in a series of 910 patients with malignant pleural mesothelioma (MPM).
26. Prognostic utility of the preoperative neutrophil/lymphocyte ratio combined with BRAF and MMR status in colorectal cancer patients.
27. Effects of qigong on quality of life, fatigue, stress, neuropathy, and sexual function in women with metastatic breast cancer: A feasibility study.
28. Marching to their own drum : British Army officers as military commandants in the Australian colonies and New Zealand 1870-1901
29. Use of inflammatory markers to triage cancer patients requiring nutritional assessment and interventions.
30. Prognostic stratification of post-docetaxel metastatic castration resistant prostate cancer (mCRPC) from a phase III randomized trial.
31. Cognitive function and fatigue in colorectal cancer (CRC) patients: A prospective longitudinal controlled study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.